Bevacizumab

SEP 4, 2026 · PHASE 1 TRIAL

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

ClinicalTrials.gov

This is a Phase 1/1b/2 early-stage trial registration with no posted results; it describes planned enrollment and primary endpoints only, reflecting hypothesis-generating and dose-finding work typical of first-in-human oncology studies.

SEP 4, 2026 · PHASE 2 TRIAL

Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC

ClinicalTrials.gov

This is a recruiting Phase 2 trial with no posted results; it represents planned evidence, not completed evidence, and cannot yet inform clinical practice.

AUG 19, 2026 · PHASE 3 TRIAL

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

ClinicalTrials.gov

This is a Phase 3 trial registration with no posted results; the study is actively recruiting and outcome data are not yet available for analysis.

AUG 12, 2026 · PHASE 2 TRIAL

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

ClinicalTrials.gov

This is a Phase 2 trial registry record with only 5 enrolled participants and no results posted; it represents early-phase work that requires confirmation.